Literature DB >> 887798

Hormone selective lipase activation in the isolated rabbit heart.

W Hsueh, P C Isakson, P Needleman.   

Abstract

The synthesis and release of PGs by the isolated perfused rabbit heart upon bradykinin stimulation results from lipase stimulation which liberates arachidonic acid for PG biosynthesis. The [14C]-labelled fatty acids, arachidonate, linoleate, and oleate, when infused into the heart preparation, were efficiently incorporated into the phospholipid pool in the heart mostly in the 2-position of phosphatidylcholine. On the other hand, [14C]-palmitate was esterified into both the 1- and the 2-position. Bradykinin released bioassayable PG when injected into the rabbit hearts, regardless of which fatty acid label was incorporated into the phospholipid pool. However, only [14C]-arachidonic acid (but not [14C]-linoleate, oleate or palmitate) was liberated from the variously labelled hearts upon hormone stimulation. This selective bradykinin effect on fatty acid release suggests that hormone stimulation either activates a specific lipase that distinguishes different fatty acids in the 2-position or activates lipase which is selectively compartmented with arachidonate-containing phospholipids. Ischemia, on the other hand, appeared to non-specifically stimulate tissue lipases, resulting in a non-selective release of oleic as well as arachidonic acid. A disproportionally large release of arachidonic acid was observed accompanying a relatively small PG (10:1 arachidonate: PG ratio) production during ischemia, as compared to bradykinin (3:1 ratio), suggesting distinct mechanisms for PG biosynthesis induced by bradykinin and ischemia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 887798     DOI: 10.1016/0090-6980(77)90135-6

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  21 in total

1.  Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.

Authors:  P Needleman; A Raz; M S Minkes; J A Ferrendelli; H Sprecher
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

2.  The bradykinin-induced coronary vasodilation. Evidence for an additional prostacyclin-independent mechanism.

Authors:  K Schrör; U Metz; R Krebs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

3.  Toxic oil syndrome, Spain: effect of oleoylanilide on the release of polysaturated fatty acids and lipid peroxidation in rats.

Authors:  A Suarez; M D Viloria; P Garcia-Barreno; A M Municio
Journal:  Arch Environ Contam Toxicol       Date:  1985-03       Impact factor: 2.804

Review 4.  How is the level of free arachidonic acid controlled in mammalian cells?

Authors:  R F Irvine
Journal:  Biochem J       Date:  1982-04-15       Impact factor: 3.857

Review 5.  The prostanoids in hemostasis and thrombosis: a review.

Authors:  J B Smith
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

6.  Cardiac and renal lipases and prostaglandin biosynthesis.

Authors:  W Hsueh; P Needleman
Journal:  Lipids       Date:  1979-02       Impact factor: 1.880

7.  Prostaglandin biosynthesis in pulmonary macrophages.

Authors:  W Hsueh
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

8.  Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues.

Authors:  P Needleman; S D Bronson; A Wyche; M Sivakoff; K C Nicolaou
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

9.  Alteration of 1,2-diacylglycerol content in ischemic and reperfused heart.

Authors:  T Kawai; K Okumura; H Hashimoto; T Ito; T Satake
Journal:  Mol Cell Biochem       Date:  1990-12-03       Impact factor: 3.396

10.  Inhibition of the release of arachidonic acid prevents the development of sarcolemmal membrane defects in cultured rat myocardial cells during adenosine triphosphate depletion.

Authors:  A Sen; J C Miller; R Reynolds; J T Willerson; L M Buja; K R Chien
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.